Background: Despite successful suppression of HIV by combination antiretroviral therapy (cART), infected cells persist for many years in patients. Long-term control of viremia by cART reveals clonal viral genomes in the blood of most patients, implying clonal expansion of some HIV infected cells. The mechanisms driving clonal expansion are unknown, but are central to HIV persistence. To address this issue, we determined the distribution of proviral integration sites in 5 patients on successful cART using a specific and highly sensitive amplification strategy that yields large numbers of virus-host junctions, identifies their exact location, and measures the relative degree of clonal expansion.
Methodology: DNA was prepared from PBMCs from 5 patients, randomly sheared, and linker-mediated PCR was used to selectively amplify both the 5’ and 3’-LTR integration site junctions, whose sequences, as well as those of the sheared breakpoints in the host DNA, were determined by Illumina pairedend sequencing. Clonal expansion of infected cells was demonstrated by the presence of DNA fragments with exactly the same integration site and different host DNA breakpoints.
Results: Analysis of integration site libraries comprising >2000 independent integration events revealed clonal expansion of HIV infected cells in all patients studied. In one patient, about half of the infected PBMCs were derived from a single infected cell. Infected clones persisted in patients for at least 11 years. Integrations in the same orientation in a specific intron of two different genes (MKL2 and BACH2), were seen in independent clones from more than one patient. In one patient, we detected 669 unique sites, of which 14 were in different expanded clones derived from independent integration events in a single 3.5 kb intron of MKL2, and 12 were in a single intron of BACH2. These data show that the expression of these genes must have been affected by these integrations in ways that made a critical contribution to the clonal expansion and/or persistence of the infected cells. Both these genes have been linked to the control of cell growth and human cancers. Other genes associated with cell growth (e.g., PAK2, STAT5B, and CYTH1) in which HIV DNA integration may have contributed to clonal expansion and persistence, were also identified in more than one patient.
Conclusions: Extensive expansion of HIV infected cell clones, some persisting for >11 years, demonstrates that the reservoir of infected cells in patients is maintained, at least in part, by cell division. Although the HIV provirus may serve as a passive marker of clonal expansion, our results show that the HIV integration site can also make an important contribution to the expansion and/or persistence of infected cell clones.